Get started Log in

1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Market Cap
HK$13.97bn
Enterprise Value
HK$14.88bn
Revenue
CNY3.72bn

Brief: Yichang Hec Changjiang Pharmaceutical Announces Rivaroxaban Tablets Approved To Launch By Nmpa

Yichang Hec Changjiang Pharmaceutical Co

25/05/2021 14:36

May 25 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd  1558.HK :
    * ANNOUNCES RIVAROXABAN TABLETS APPROVED TO LAUNCH BY NMPA

Source text for Eikon:  ID:nHKS9dRL76 
Further company coverage:  1558.HK

Recent news on Yichang Hec Changjiang Pharmaceutical Co

Brief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
05/08/2025 02:21
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
27/03/2025 15:29
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
05/12/2024 15:24
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
12/11/2024 15:29
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million
30/08/2024 15:25